Kymera Therapeutics Inc (KYMR)
47.81
+2.83
(+6.29%)
USD |
NASDAQ |
Nov 25, 15:43
Kymera Therapeutics Total Assets (Quarterly): 1.035B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.035B |
| June 30, 2024 | 826.02M |
| March 31, 2024 | 868.25M |
| December 31, 2023 | 575.76M |
| September 30, 2023 | 552.38M |
| June 30, 2023 | 581.94M |
| March 31, 2023 | 613.90M |
| December 31, 2022 | 603.13M |
| September 30, 2022 | 638.47M |
| June 30, 2022 | 523.42M |
| Date | Value |
|---|---|
| March 31, 2022 | 563.06M |
| December 31, 2021 | 605.90M |
| September 30, 2021 | 642.45M |
| June 30, 2021 | 434.39M |
| March 31, 2021 | 464.55M |
| December 31, 2020 | 487.18M |
| September 30, 2020 | 507.36M |
| June 30, 2020 | 181.11M |
| December 31, 2019 | 116.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
116.70M
Minimum
Dec 2019
1.035B
Maximum
Sep 2024
569.52M
Average
575.76M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 90.88B |
| Voyager Therapeutics Inc | 426.04M |
| Denali Therapeutics Inc | 1.454B |
| Vir Biotechnology Inc | 1.498B |
| CEL-SCI Corp | 24.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 141.91M |
| Shareholders Equity (Quarterly) | 892.93M |
| Current Ratio | 8.548 |